Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Syntara expands scar trial as earlier compound causes skin reactions
October 1, 2026 - - Latest News -
Neurizon hands the reins to Chris Bremer as ALS trial heads for critical readout
October 1, 2026 - - Latest News -
Vitrafy takes its frozen platelet push to America's Midwest
September 30, 2026 - - Latest News -
Paradigm Biopharmaceuticals enters voluntary administration after Phase 3 setback
September 30, 2026 - - Latest News -
FDA fast tracks Telix scan that could spare men prostate biopsies
September 30, 2026 - - Latest News -
Nexsen turns to Shenzhen partner to speed up its bid for the Group B strep market
September 29, 2026 - - Latest News -
Five Australian heart devices share $4.2 million on World Heart Day
September 29, 2026 - - Latest News